Eine vollständige Bewerbung in einer Minute
Maßgeschneiderter Lebenslauf und Anschreiben – versandbereit.
IQVIA is seeking a senior biosimilars leader to own the commercial and market access strategy across Poland and neighbouring regions. You will drive pricing, tender strategy, and regional P&L with significant autonomy and cross-functional impact.
You will lead prioritization across immunology, oncology, haematology and ophthalmology, shaping reimbursement pathways and access for patients while partnering with distributors and healthcare stakeholders. Fluency in Polish and English is required.
Take commercial ownership of a growing biosimilars portfolio across an important European region.
This is a senior, high-impact role combining commercial leadership, market access, pricing and tender strategy. You will have significant autonomy and responsibility for driving portfolio growth, expanding patient access and delivering sustainable commercial performance across Poland and the wider region.
You will lead commercial performance and market access execution across Poland, Nordics and the Baltic markets, while contributing to the broader regional strategy.
Working across a portfolio spanning immunology, oncology, haematology and ophthalmology, you will develop and execute commercial, pricing and tender strategies within complex hospital and reimbursement environments.
This is an opportunity for an experienced biosimilars professional to take broad ownership of a strategically important region and play a key role in its continued growth.
The potential base salary range for this role is PLN 303,000–570,000 annually.
The actual base salary offered will depend on a number of factors, including relevant knowledge, skills, experience, education, location and working arrangements.
In addition to base salary, the overall package includes: